Questions and Answers
What method is primarily used to administer glucagon during hypoglycemic emergencies?
What is a significant limitation of glucagon when hepatic glycogen stores are depleted?
What is a common side effect associated with glucagon use?
What mechanism underlies the hyperglycemic effect of diazoxide?
Signup and view all the answers
Which of the following properties does glucagon share with diazoxide?
Signup and view all the answers
Which channel does diazoxide interact with to exert its effects?
Signup and view all the answers
What is the primary mechanism of action of metformin in the liver?
Signup and view all the answers
Which of the following effects is NOT associated with the activation of AMPK?
Signup and view all the answers
What is a common side effect of thiazolidinediones?
Signup and view all the answers
What is the primary action of α-glucosidase inhibitors in the intestinal tract?
Signup and view all the answers
Which process is NOT facilitated by the binding of thiazolidinediones to PPARγ?
Signup and view all the answers
Which statement regarding metformin's pharmacokinetics is true?
Signup and view all the answers
Which of the following is a common side effect of α-glucosidase inhibitors?
Signup and view all the answers
The primary effect of activated AMPK includes all of the following EXCEPT:
Signup and view all the answers
What mechanism do gliflozins utilize to lower blood glucose levels?
Signup and view all the answers
What is a notable pharmacokinetic characteristic of acarbose?
Signup and view all the answers
How do thiazolidinediones primarily affect glucose metabolism?
Signup and view all the answers
Which patient demographic is particularly at higher risk for urinary tract infections due to gliflozin use?
Signup and view all the answers
The transport of metformin into cells is primarily mediated through which of the following?
Signup and view all the answers
What type of reaction can occur with acarbose regarding hepatic transaminases?
Signup and view all the answers
Which of the following correctly describes the administration method of liraglutide?
Signup and view all the answers
Which of the following statements about exenatide is true?
Signup and view all the answers
Which alteration in the amino acid sequence of insulin results in increased stability and solubility?
Signup and view all the answers
What is the primary mechanism by which glucose stimulates insulin secretion?
Signup and view all the answers
Which of the following combinations represents a mixed insulin formulation?
Signup and view all the answers
Which of the following is NOT a common side effect of insulin therapy?
Signup and view all the answers
What distinguishes the first generation sulphonylureas from the second generation?
Signup and view all the answers
Which insulin formulation is characterized by prolonged action and a predictable kinetic profile?
Signup and view all the answers
Which glucose transporter is activated by the binding of insulin to its receptor?
Signup and view all the answers
What effect does insulin have that contributes to weight gain?
Signup and view all the answers
What is a significant side effect of Thiazolidinediones that could exacerbate a specific cardiovascular condition?
Signup and view all the answers
Which statement best describes the metabolism of Thiazolidinediones?
Signup and view all the answers
What effect does co-administration of rifampin have on Thiazolidinediones?
Signup and view all the answers
What is the primary action of Dipeptidyl peptidase-4 (DPP-4) inhibitors like sitagliptin?
Signup and view all the answers
Which of the following statements about GLP-1 agonists is TRUE?
Signup and view all the answers
What is the primary pharmacokinetic characteristic of Gliptins?
Signup and view all the answers
Which of the following is NOT a reported side effect of Gliptins?
Signup and view all the answers
Which group of patients should avoid the use of Thiazolidinediones?
Signup and view all the answers
Study Notes
Insulin Variants and Mechanisms
- Alterations in human insulin's amino acid sequence enhance stability and modify action duration, such as insulin lispro from reversing proline and lysine.
- Mixed insulin formulations include 70:30 combinations of NPH and regular insulin, as well as lispro protamine/lispro in ratios of 50/50 and 75/25.
- Insulin glargine offers prolonged effects with a predictable kinetic profile.
Insulin Secretion Regulation
- Glucose serves as the primary insulin secretagogue.
- ATP-sensitive potassium channels contribute to membrane depolarization, initiating insulin release from storage vesicles.
- Insulin binds to enzyme-linked transmembrane receptors, activating glucose transport processes via Glut-4 in adipose and muscle tissues.
Insulin Side Effects
- Common side effects include hypoglycemia, weight gain, allergic reactions, injection site reactions, lipoatrophy, and lipohypertrophy.
Oral Hypoglycemic Agents
Sulphonylureas
- Substituted arylsulphonylureas, divided into first-generation (e.g., tolbutamide, chlorpropamide) rarely used due to severe hypoglycemia risk.
- Second-generation includes glibenclamide, gliclazide, glipizide, and glimepiride, with less severe hypoglycemic effects.
Metformin
- Acts primarily by suppressing hepatic gluconeogenesis and is best absorbed in the small intestine; does not bind plasma proteins.
- Common side effects include gastrointestinal disturbances (anorexia, diarrhea, nausea) and lactic acidosis, with a rare incidence of hypoglycemia.
Thiazolidinediones (Glitazones)
- Rosiglitazone and pioglitazone bind to PPARγ in adipose tissue, enhancing glucose and fatty acid uptake but contributing to weight gain.
- Slow onset of blood glucose-lowering effects, with significant side effects including weight gain and fluid retention, potentially exacerbating heart failure.
Dipeptidyl Peptidase-4 (DPP-4) Inhibitors (Gliptins)
- Inhibit DPP-4 enzyme, enhancing bioavailability of incretins like GLP-1 and GIP to lower blood glucose levels.
- Common side effects include nausea, stomach pain, and flu-like symptoms.
GLP-1 Agonists
- These agents activate GLP-1 receptors, stimulating insulin biosynthesis and release.
- Administered via subcutaneous injections, with side effects including nausea, vomiting, and delayed gastric emptying.
α-Glucosidase Inhibitors
- Inhibit α-glucosidase in the intestine, reducing starch and disaccharide absorption, resulting in decreased postprandial plasma glucose.
- Examples include acarbose and miglitol, with common gastrointestinal side effects such as flatulence and diarrhea.
SGLT-2 Inhibitors (Gliflozins)
- Agents like dapagliflozin and canagliflozin block sodium-glucose co-transport in kidneys, reducing glucose absorption and blood glucose levels.
- Short half-life and plasma protein binding; they increase urinary tract infection risk.
Glucagon and Diazoxide for Hypoglycemia
- Glucagon, produced via recombinant DNA, treats severe hypoglycemia, administered intravenously, intramuscularly, or subcutaneously.
- Diazoxide, an oral vasodilator with hyperglycemic effects, prevents insulin secretion through KATP channel interaction.
Studying That Suits You
Use AI to generate personalized quizzes and flashcards to suit your learning preferences.
Description
This quiz explores the structural modifications of human insulin, including its amino acid sequence and protein structure alterations. Learn about various insulin types such as insulin lispro, NPH, and glargine, and their effects on solubility and action duration.